Obstetric outcomes following immedicate versus delayed intravenous Oxytocin after amniotomy among parturients: A randomized clinical trial

Not Applicable

• Conditions: Pregnancy and Childbirth; labour augmentation

• Registration Number: PACTR201803003123163
• Lead Sponsor: Kenyatta National Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-20
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 202

Inclusion Criteria

Pregnant mothers who:
1.Provide informed consent
2.Have intact membranes at 37 completed weeks or greater.
3. Have singleton vertex pregnancies.
4.Require ARM (at cervical dilatation of 4 cm) for example due to inadequate uterine contractions or poor progress in labour.

Exclusion Criteria

Pregnant mothers in labour with:
1.Multiple gestation.
2.Malpresentation (non-vertex)
3.Previously had uterine surgery.
4.Virally unsuppressed HIV infection.
5.Non-reassuring fetal status prior to amniotomy.
6.Post amniotomy meconium stained liquor, fetal tachycardia, fetal bradycardia, umbilical cord or limb prolapse.
7.Antepartum hemorrhage due to any cause.
8.Hypertensive disease, Diabetes and Cardiac disease in pregnancy.
9.Known/ suspected fetal growth restriction.
10.Parity > 5 (grand multipara)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Amniotomy to delivery duration in hours and minutes

Secondary Outcome Measures

Name	Time	Method
Mode of delivery;maternal satisfaction with augmentation process;neonatal outcome;incidence of umbilical cord prolapse;incidence of uterine hyperstimulation;incidence of adverse neonatal outcomes